193 related articles for article (PubMed ID: 11600362)
1. BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.
Rodriguez-Cerrato V; Ghaffar F; Saavedra J; Michelow IC; Hardy RD; Iglehart J; Olsen K; McCracken GH
Antimicrob Agents Chemother; 2001 Nov; 45(11):3098-103. PubMed ID: 11600362
[TBL] [Abstract][Full Text] [Related]
2. Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Pfister M; Täuber MG
Antimicrob Agents Chemother; 2002 Jan; 46(1):184-7. PubMed ID: 11751131
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.
Rodriguez-Cerrato V; McCoig CC; Michelow IC; Ghaffar F; Jafri HS; Hardy RD; Patel C; Olsen K; McCracken GH
Antimicrob Agents Chemother; 2001 Nov; 45(11):3092-7. PubMed ID: 11600361
[TBL] [Abstract][Full Text] [Related]
4. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Pfister M; Acosta F; Cottagnoud M; Flatz L; Kühn F; Müller HP; Stucki A
Antimicrob Agents Chemother; 2004 Oct; 48(10):3928-33. PubMed ID: 15388454
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
[TBL] [Abstract][Full Text] [Related]
7. Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci.
Rodriguez-Cerrato V; McCoig CC; Saavedra J; Barton T; Michelow IC; Hardy RD; Bowlware K; Iglehart J; Katz K; McCracken GH
Antimicrob Agents Chemother; 2003 Jan; 47(1):211-5. PubMed ID: 12499193
[TBL] [Abstract][Full Text] [Related]
8. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
[TBL] [Abstract][Full Text] [Related]
9. Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model.
Suntur BM; Yurtseven T; Sipahi OR; Buke C; Buke M
Int J Antimicrob Agents; 2005 Sep; 26(3):258-60. PubMed ID: 16099624
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
Ostergaard C; Sørensen TK; Knudsen JD; Frimodt-Møller N
Antimicrob Agents Chemother; 1998 Jul; 42(7):1706-12. PubMed ID: 9661008
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of T-3811ME (BMS-284756), a new des-F(6)-quinolone, for treatment of meningitis caused by penicillin-resistant Streptococcus pneumoniae in rabbits.
Takahata M; Yamada H; Morita T; Furubou S; Minami S; Todo Y; Watanabe Y; Narita H
Antimicrob Agents Chemother; 2002 Jun; 46(6):1760-5. PubMed ID: 12019087
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Friedland IR; Paris M; Ehrett S; Hickey S; Olsen K; McCracken GH
Antimicrob Agents Chemother; 1993 Aug; 37(8):1630-6. PubMed ID: 8215275
[TBL] [Abstract][Full Text] [Related]
13. Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits.
Nau R; Schmidt T; Kaye K; Froula JL; Täuber MG
Antimicrob Agents Chemother; 1995 Mar; 39(3):593-7. PubMed ID: 7793857
[TBL] [Abstract][Full Text] [Related]
14. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG
Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696
[TBL] [Abstract][Full Text] [Related]
15. Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitis.
Vivas M; Force E; Garrigós C; Tubau F; Platteel AC; Ariza J; Cabellos C
J Antimicrob Chemother; 2014 Nov; 69(11):3020-6. PubMed ID: 24962033
[TBL] [Abstract][Full Text] [Related]
16. Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
Antimicrob Agents Chemother; 2002 May; 46(5):1607-9. PubMed ID: 11959614
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
París MM; Hickey SM; Trujillo M; Shelton S; McCracken GH
Antimicrob Agents Chemother; 1995 Jun; 39(6):1243-6. PubMed ID: 7574509
[TBL] [Abstract][Full Text] [Related]
18. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P
J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of gatifloxacin in experimental models of pneumococcal meningitis.
McCracken GH
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S45-50. PubMed ID: 10984328
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis.
Lutsar I; Friedland IR; Wubbel L; McCoig CC; Jafri HS; Ng W; Ghaffar F; McCracken GH
Antimicrob Agents Chemother; 1998 Oct; 42(10):2650-5. PubMed ID: 9756771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
